The comprehensive assessment of local immune status of ovarian cancer by the clustering of multiple immune factors
- 1 December 2011
- journal article
- Published by Elsevier in Clinical Immunology
- Vol. 141 (3) , 338-347
- https://doi.org/10.1016/j.clim.2011.08.013
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Education, Culture, Sports, Science and Technology
This publication has 42 references indexed in Scilit:
- Phase III Randomized Trial Assessing Rofecoxib in the Adjuvant Setting of Colorectal Cancer: Final Results of the VICTOR TrialJournal of Clinical Oncology, 2010
- Ovarian cancer immunotherapy: opportunities, progresses and challengesJournal of Hematology & Oncology, 2010
- Classification using hierarchical clustering of tumor-infiltrating immune cells identifies poor prognostic ovarian cancers with high levels of COX expressionLaboratory Investigation, 2009
- Prognostic Effect of Epithelial and Stromal Lymphocyte Infiltration in Non–Small Cell Lung CancerClinical Cancer Research, 2008
- TGFβ in CancerCell, 2008
- PD-1 and Its Ligands in Tolerance and ImmunityAnnual Review of Immunology, 2008
- The impact of T‐cell immunity on ovarian cancer outcomesImmunological Reviews, 2008
- Cancer immunoediting from immune surveillance to immune escapeImmunology, 2007
- Programmed cell death 1 ligand 1 and tumor-infiltrating CD8+T lymphocytes are prognostic factors of human ovarian cancerProceedings of the National Academy of Sciences, 2007
- Cancer immunoediting: from immunosurveillance to tumor escapeNature Immunology, 2002